Trius Therapeutics Inc: key financial figures for fiscal year 2012 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2012)
- $27.2M
- Net Income/Loss (FY2012)
- -$53.9M
- Total Assets (FY2012)
- $75.3M
- Total Equity (FY2012)
- $56.8M
- Cash Flows from Operating Activities (FY2012)
- -$49.5M
Source: Trius Therapeutics Inc 10-K filing (FY2012). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
